C.
Pyrogens (e.g., IL-1, TNF-alpha).
✓
A.
Decreased capillary hydrostatic pressure.
✓
B.
Increased plasma oncotic pressure.
✓
C.
Increased capillary hydrostatic pressure due to fluid overload and decreased cardiac output.
✓
D.
Increased lymphatic drainage.
✓
A.
Excessive use of loop diuretics.
✓
B.
Diabetic ketoacidosis (DKA) with potassium shifting out of cells.
✓
A.
Autoantibodies that attack the body's own tissues.
✓
B.
Increased complement proteins.
✓
C.
Decreased inflammatory mediators.
✓
D.
Excessive B-cell suppression.
✓
A.
Bronchial smooth muscle hypertrophy.
✓
B.
Alveolar wall destruction and loss of elastic recoil.
✓
C.
Reversible airway inflammation.
✓
D.
Increased mucus gland hyperplasia.
✓
A.
Excessive clot formation leading to widespread microvascular thrombosis and consumption of clotting factors, followed by bleeding.
✓
B.
Only excessive bleeding with no clot formation.
✓
C.
Increased production of platelets.
✓
D.
Decreased fibrinolysis.
✓
B.
Autosomal recessive.
✓
A.
Increased intravascular protein synthesis.
✓
B.
Decreased capillary permeability.
✓
C.
Increased capillary hydrostatic pressure and increased capillary permeability.
✓
D.
Decreased lymphatic drainage.
✓
